logo
  

Target Recalls Cloud Island 4-Piece Plush Toy Sets

target dec02 lt

Discount retailer Target Corp. is recalling about 23,400 units of Cloud Island 4-Piece Plush Toy Sets citing choking risk, the U.S. Consumer Product Safety Commission said.

The recall involves toy vehicle sets, which are a soft, knitted construction and include a blue car, a yellow bus, a red tractor, and a green truck each with a rattle inside. Item number 030-02-1042 is printed on the fabric tag attached to the bottom each vehicle.

The toy sets, manufactured in China, were sold at Target stores nationwide and online at www.target.com from March 2022 through August 2022 for about $20.

According to the agency, the tires on the toy vehicles can detach, posing a choking hazard to children.

The recall was initiated after the Minneapolis, Minnesota-based firm received four reports of tires detaching from toy vehicles. However, no injuries have been reported to date related to the recalled product.

Consumers are urged to immediately take the recalled plush toys away from young children and return them to any Target store for a full refund.

Target in October had recalled about 12,800 tea kettles due to fire and burn hazards.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT